Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Kalyterian website

<< Previous

Bullboard Posts

Next >>

Post by Chritterson Nov 24, 2020 9:12am

874 Views

Post# 31959450

Kalyterian website

Does anyone else besides me think that Kalyterian website that keeps looking for people to join is fishy?
They always have question and Answer periods with Robert, The Admin hides his attentity, I think its the CEO Robert pretending to be someone else trying to Rally the Troups up to buy buy buy!! Who else would would pump a stock thats been Halted for 5 Months and excuse after excuse to keep defending the stock. Somethin just doesnt sound right.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season